Ibex Ltd (IBEX) Stock Price & Analysis

Ibex Ltd (IBEX) rose 3.88% to USD 33.46 as of July 25, 2026 at 19:34 UTC, according to Nexqual real-time market data.

IBEX last closed at USD 32.21; the session ranged USD 32.43–33.84 on volume of 64,212 shares. Market capitalization is $448.00M, with a 52-week range of USD 25.94–42.99 (NGM). Source: Nexqual, July 25, 2026 at 19:34 UTC.

Key Statistics (as of July 25, 2026 at 19:34 UTC)

PriceUSD 33.46
Change▲ 3.88% (up)
Previous CloseUSD 32.21
OpenUSD 32.43
Day RangeUSD 32.43 – 33.84
52-Week RangeUSD 25.94 – 42.99
Volume64,212 shares
Market Cap$448.00M
ExchangeNGM

Technical Analysis (IBEX)

Nexqual's technical model rates IBEX "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 19:34 UTC.

Overall SignalSTRONG BUY
RSI (14)54.86 (neutral)
vs SMA50Above (USD 31.7)
MACD0.77 (positive)

Analyst Ratings (IBEX)

Wall Street analysts rate IBEX "None" based on 2 analysts, with a mean price target of USD 37.5 (range USD 35–40), per Nexqual as of July 25, 2026 at 19:34 UTC.

Consensus RatingNone
Analyst Count2
Mean TargetUSD 37.5
High TargetUSD 40
Low TargetUSD 35
Buy / Hold / Sell0 / 2 / 0

Earnings (IBEX)

Next Earnings Date2026-09-10
EPS EstimateUSD 0.85
Revenue Estimate$160.02M

Recent Earnings History

QuarterActual vs Estimate
2026-03-31USD 0.91 vs est 0.86 ▲ beat
2025-12-31USD 0.87 vs est 0.79 ▲ beat
2025-09-30USD 0.9 vs est 0.74 ▲ beat
2025-06-30USD 0.87 vs est 0.7 ▲ beat

Source: Nexqual, July 25, 2026 at 19:34 UTC.

Financials & Fundamentals (IBEX)

Total Revenue$626.95M
Revenue Growth (YoY)+16.80%
Gross Margin+29.87%
Operating Margin+9.83%
Profit Margin+7.52%
ROE+33.11%
Debt / Equity37.96
Current Ratio1.95
Total Cash$15.41M
Total Debt$61.02M
Free Cash Flow$31.65M

Source: Nexqual, July 25, 2026 at 19:34 UTC.

Financial Health Score (IBEX)

Nexqual rates Ibex Ltd's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 19:34 UTC.

GrowthSolid — Revenue +10% YoY (annual)
ProfitabilitySolid — Gross margin 30%, operating 10%
Balance SheetSolid — $15M cash vs $61M debt
Cash FlowSolid — FCF $32M, 6% margin
EfficiencyStrong — ROE 33%, ROA 13.0%

Ownership (IBEX)

Insider Ownership+6.97%
Institutional Ownership+99.68%
Shares Outstanding13.39M
Float10.89M
Short % of Float+1.77%

Source: Nexqual, July 25, 2026 at 19:34 UTC.

Leadership (IBEX)

Ibex Ltd is led by Robert T. Dechant (age 63), CEO & Director, per Nexqual as of July 25, 2026 at 19:34 UTC.

CEO & DirectorRobert T. Dechant (age 63)
Chief Financial OfficerTaylor C. Greenwald (age 57)
Chief Operating OfficerDavid Afdahl (age 51)
Chief Marketing & Strategic Accounts OfficerJulie M. Casteel (age 63)
Chief Technology OfficerMichael Ringman (age 53)

Major Backers & Investors (IBEX)

Notable institutional backers of Ibex Ltd include American Century Companies Inc, Acadian Asset Management. LLC, Two Sigma Investments, LP, according to Nexqual as of July 25, 2026 at 19:34 UTC.

Active Investors

InvestorStake
American Century Companies Inc9.36%
Acadian Asset Management. LLC3.09%
Two Sigma Investments, LP2.86%
Royce & Associates LP2.72%
JPMorgan2.54%
Ameriprise Financial, Inc.2.52%
Boston Partners2.14%
Wellington Management2.09%

Index Funds (Passive)

FundStake
BlackRock9.01%
Dimensional Fund Advisors2.68%

Source: Nexqual, July 25, 2026 at 19:34 UTC.

From Ibex Ltd's Latest SEC 10-K Filing (filed 2025-09-11)

Key Strengths & Strategy (as disclosed to the SEC)

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
IMXIInternational Money Express, InUSD 13.03▼ 1.44%
IIIVi3 Verticals, Inc.USD 20.19▲ 3.12%
HBTHBT Financial, Inc.USD 33.29▲ 2.81%
HLIOHelios Technologies, Inc.USD 79.83▼ 1.11%
INBXInhibrx Biosciences, Inc.USD 81.55▼ 5.09%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 19:34 UTC. This page is informational and not investment advice.